TherapeuticsMD, Inc. (TXMD) — Operating Cash Flow
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | $2.45M | +109.7% |
| 2024 | $1.17M | +105.1% |
| 2023 | -$23.08M | -346.6% |
| 2022 | $9.36M | +117.0% |
| 2021 | -$55.13M | — |
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | $2.45M | +109.7% |
| 2024 | $1.17M | +105.1% |
| 2023 | -$23.08M | -346.6% |
| 2022 | $9.36M | +117.0% |
| 2021 | -$55.13M | — |